Search

Your search keyword '"Hellebust TP"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Hellebust TP" Remove constraint Author: "Hellebust TP" Language english Remove constraint Language: english
49 results on '"Hellebust TP"'

Search Results

1. The current status of brachytherapy in Europe - A GEC-ESTRO Brachy-HERO survey.

2. Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy.

3. MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.

4. AAPM Task Group Report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy.

5. Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes.

6. Survival prediction in patients with gynecological cancer irradiated for brain metastases.

7. Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters.

8. Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy.

9. Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

10. Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial.

11. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.

12. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.

13. Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer.

14. A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients.

15. GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy.

16. Dose deviations induced by respiratory motion for radiotherapy of lung tumors: Impact of CT reconstruction, plan complexity, and fraction size.

17. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.

18. Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer.

19. Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy.

20. Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer: Evolution of Practice From EMBRACE-I to II.

21. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.

22. Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy.

23. Place of modern imaging in brachytherapy planning.

24. Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography.

25. Impact of dose escalation and adaptive radiotherapy for cervical cancers on tumour shrinkage-a modelling study.

26. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.

27. Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.

28. Spatial dosimetric sensitivity of contouring uncertainties in gynecological 3D-based brachytherapy.

29. Comparison of high-dose-rate (192)Ir source strength measurements using equipment with traceability to different standards.

30. Quality assurance in radiotherapy on a national level; experience from Norway: the KVIST initiative.

31. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.

32. Long-term outcomes after pelvic radiation for early-stage endometrial cancer.

33. A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy.

34. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study.

35. Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy.

36. Patterns of care for brachytherapy in Europe: updated results.

37. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.

38. Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly.

39. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer.

40. Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems.

41. Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation.

42. Dose optimisation in single plane interstitial brachytherapy.

43. Comparative analyses of the dynamic properties of the bladder wall studied by repetitive pelvic CT scans of patients and cryo-sections of cadavers.

44. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

45. Comparative analyses of the dynamic properties of the rectum studied by cryo-sections of human cadavers and pelvic CT scans of patients.

46. Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept.

47. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.

48. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.

49. Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel.

Catalog

Books, media, physical & digital resources